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Summary 
Engagement of the T cell antigen receptor (TCP,.) results in activation of several tyrosine kinases 
leading to tyrosine phosphorylation of protein substrates and activation of multiple biochemical 
pathways. TCR-mediated activation of the src-family kinases, Lck and Fyn, results in tyrosine 
phosphorylation of the TCIL~"  and CD3 chains. The site of phosphorylation in these chains is 
the tyrosine-based  activation motif (TAM), a 15-16 amino acid module containing two tyrosine 
residues. Tyrosine-phosphorylated TAMs serve as targets for binding of the zeta-associated pro- 
tein (ZAP-70) tyrosine kinase via its tandem SH2 domains. This binding correlates with activa- 
tion of ZAP-70, a critical event in T cell activation.  To further define the structural requirements 
for ZAP-70 interaction with the TCR, we developed a binding assay using immobilized glutathione 
S-transferase fusion proteins containing the NH2- and/or COOH-terminal SH2 domains of ZAP- 
70, and soluble synthetic peptides with the sequence of the cytoplasmic region of the TCR~" 
chain (TCR.~'~yt) or individual TCR~" and CD3e TAM motifs. Direct binding studies demon- 
strated that the tandem ZAP-70 SH2 domains bind phosphorylated, but not nonphosphorylated, 
TCIL~'~st. The NH2-terminal ZAP-70 SH2 domain also binds to TCIL~'~st but with 100-fold 
lower affinity. No binding was observed with the COOH-terminal ZAP-70 SH2 domain. Similar 
studies demonstrated that the ZAP-70 tandem SH2 domain can bind a TCR~'3 TAM peptide 
in which both tyrosine residues are phosphorylated: Little or no binding was observed with 
peptides phosphorylated at only one tyrosine residue, or a nonphosphorylated peptide. Binding 
of the tandem SH2 domains to the other two TCRg" TAM peptides and to a CD3e TAM peptide 
was also observed.  All four doubly tyrosine phosphorylated TAM peptides cross-compete with 
each other for binding to the tandem SH2 domains of ZAP-70.  The affinity of these peptides 
for the tandem SH2 construct demonstrated a hierarchy of TAM~'I>--TAM~'2>TAMe>--TAM~'3. 
The results provide further evidence that the ZAP-70 interaction with the TCR requires prior 
phosphorylation of both tyrosine residues within a TAM motif. Binding of ZAP-70 to phospho- 
TAMs is notable for the high level of cooperativity between the two SH2 domains, which indi- 
vidually demonstrate tow affinity interaction with the ligand. The cooperativity ensures higher 
affinity for the doubly phosphorylated ligand. Affinity differences of as much as 30-fold indicates 
a significant  specificity of interaction of ZAP-70  SH2 domains for different  phospho-TAMs. 
S 
tudies with mutant T cell lines and transfectants  expres- 
sing chimeric TCR molecules have identified a 15-16 
amino acid sequence motif in the cytoplasmic portion of the 
TCR~" and CD3 chains subunits that is both necessary and 
sufficient for coupling the receptor to early and late signaling 
events. The sequence, first noted by Reth (1), and referred 
to as a tyrosine-based activation motif (TAM), has the general 
structure  YXX(L/I)X~7_s)YXX(L/I),  and  is  sufficient  to 
confer upon a chimeric receptor the potential to induce cell 
activation after receptor cross-linking (2, 3). TAM motifs are 
found in three copies in the TCR~" chain and in one copy 
each in the CD37, 5, and e chains (1, 3-6). From the time 
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volved in coupling the TCR to downstream effector mole- 
cules.  Investigators have suggested that  multiple TAMs in 
the TCR are required for binding multiple copies of a partic- 
ular molecule in order to amplify the signal given by a rare 
binding event (7).  Others have postulated that  each of the 
different TAM motifs within a single TCR may function as 
a docking region  for distinct  effector molecules (3). 
T  cell activation via the TCR is dependent  on multiple 
protein tyrosine kinases (PTKs) that phosphoryhte numerous 
substrates (8), including the TCR/CD3 subunits that are phos- 
phorylated on their TAM motifs (9-11).  These multiple TCR 
subunits lack intrinsic  PTK activity; instead,  they interact 
with and activate,  cytoplasmic PTKs that couple the receptor 
to the signaling  apparatus. 
Four PTKs have been implicated in this process:  the src 
family members Lck and Fyn, and the syk family members, 
Syk and zeta-associated protein (ZAP-70) (reviewed in refer- 
ences 7, 12). One function of the Lck and/or Fyn molecules 
activated directly or indirectly by the TCR is the tyrosine 
phosphorylation  of the  TCR TAM motifs.  The Syk PTK 
is found primarily in B  calls,  mast cells,  thymocytes, and, 
at a low level, in some T cell lines. The ZAP-70 PTK is found 
in the cytosol of resting T calls and, upon TCR stimulation, 
is rapidly recruited to the TCR/CD3 complex (13, 14). This 
sequential PTK activation model has been studied in COS 
cells using transfected TCR chimeras  and PTKs (15).  The 
association of the ZAP-70 kinase with tyrosine phosphorylated 
TCR subunits after T  cell activation has been shown to be 
mediated by the tandem SH2 domains of this kinase (15-17). 
In the present study we analyze the biochemical and struc- 
tural requirements  for ZAP-70 interaction  with  individual 
TAM motifs. Using glutathione S-transferase  (GST) fusion 
proteins containing the NH2- and/or COOH-terminal SH2 
domains of ZAP-70, we study binding requirements  using 
nonphosphorylated or tyrosine phosphorylated synthetic pep- 
tides that correspond in sequence to the TCR~" cytoplasmic 
region (TClk~'cyt) or to the CD3e and to each of the three 
TCR~" TAM motifs. We find that the tandem SH2 domains 
bind the doubly tyrosine phosphorylated CD3e TAM and 
the three doubly tyrosine phosphorylated TAMs from  the 
TCR~" chain.  Competition binding  studies reveal  that  the 
affinities  of these binding  interactions  differ. 
Materials and Methods 
Peptides and GST Fusion Proteins.  The cytoplasmic domain of 
the TCR~" (TCR~'w; residues 52-164) has been chemically synthe- 
sized as described (18). Individual  phosphorylated  TAM motif- 
containing peptides (Table 1), were prepared by Michael Berne (Tufts 
University, Boston, MA). A second set of nonphosphorylated  2l- 
iner  TAM~'3 (HDGLYQGLSTATKDTYDALHM)  and  22-met 
TAM~'2 (QEGLYNELQKDKMAEAYSEIGM) peptides were pur- 
chased from Peptide Technologies Corp. (Gaithersburg, MD). Pep- 
tide concentrations  were verified by amino acid analysis. Briefly, 
peptides were hydrolyzed in 6 M HC1 at 150~  for 60 rain. The 
hydrolyzed samples were derivatized with phenylisothioqanate and 
the  resulting  derivatized  amino  acids were  quantitated  on  a 
Table 1.  Amino Acid Sequences of TAM Peptides 
TAMfi 
TAM~'2 
TAM~'3 
TAMe 
LYNELNKGRREE-YDVLD 
LYNELQKDKMAEAYSE  I  G 
LYQGLSTATKDT-YDALH 
DYEP  I  RKGQRDL-YSGLN 
Amino acid sequence  of synthetic peptides used in this study were der- 
ived from the human TCRs  ~ or CD3e chains. Conserved tyrosine (Y) 
and leucine/isoleucine (L/I) residues are indicated with boldface letters. 
Additional peptides were used in which the NH2-terminal (pNTAM), 
COOH-terminal (pcTAM), or both (p2TAM) tyrosine residues were 
replaced by phosphotyrosine. 
PICOTAG amino acid analysis system (model 840; Waters, Med- 
ford, MA). 
TCR~, and individual TAM peptides were phosphorylated  in 
vitro with recombinant Lck essentially as described (18). To ensure 
highest possible stoichiometry ofphosphorylated peptide, an excess 
of ATP was used over available tyrosine residues in each reaction. 
7-[32p]ATP (ICN Radiochemicals, Irvine, CA) was added to ki- 
nase reactions to a known specific activity in order to (a) allow 
quantitation  of reaction efficiency; and (b) permit  calculation of 
peptide concentration  after repurification via Cerenkov counting. 
Peptides were repurified by reverse  phase-HPLC on a Waters 600E 
system to remove unreacted ATP and Lck. TCR~'~ was repurified 
on a C4 column  (2.1  x  150 ram;  Vydac Hesperia, CA) eluting 
bound peptide with a short acetonitrile gradient. Individual TAM 
peptides were repurified on a Vydac C~s column (4.6  x  250 ram), 
eluting  bound peptides with  a shallow acetonitrile  gradient  to 
achieve separation of the singly and doubly phosphorylated forms. 
A Sciex TOBY single quadrupole mass spectrometer was used to 
identify the nonphosphorylated, singly phosphorylated and doubly 
phosphorylated TAM-containing HPLC peaks. GST-ZAP-70  fusion 
proteins  were prepared as described (16). 
Binding Assay.  2-4/zg of GST or GST fusion proteins com- 
prising  the  SH2 domains  from  ZAP-70  were immobilized  on 
glutathione agarose beads. These beads were washed and incubated 
with the indicated concentrations of 32p-labeled peptides with or 
without competing  "cold" peptides in 0.5 ml buffer A (25 mM 
Tris-HC1, pH  7.6, 150 mM  NaC1, 1%  Triton  X-100,  1 mM 
Na3VO,, 5 mM EDTA, 10/~g/ml  each leupeptin and aprotinin, 
and 25 #M p-nitrophenyl p'-guanidinobenzoate).  After 1 h of in- 
cubation at 4~  on a rotator,  the beads were extensively washed 
in buffer A, and bound radioactivity was determined by SDS-PAGE 
(on 15% gels) and autoradiography, or by scintillation counting. 
Results and Discussion 
Specific Binding  of Tyrosine Phosphorylated TCR~'9,  to the 
ZAP-70 Tandem SH2 Domains.  Experiments with immobi- 
lized fusion proteins containing the ZAP-70 tandem SH2 do- 
mains demonstrated that they can precipitate the TCR~" and 
CD3e chains from lysates of activated Jurkat T calls (16). The 
following studies were performed to confirm that the inter- 
action of ZAP-70 SH2 domains and TCR represents a direct 
interaction.  Moreover, we wished to compare the relative affini- 
ties of individual and tandem SH2 domains for binding to 
the TCR~" chain. We established a sensitive binding assay using 
376  ZAP-70  Binding Specificity to TCR Tyrosine-based  Activation Motifs ZAP(SH2)2 Domains Exhibit Specific Binding to the Doubly 
Tyrosine Phosphorylated TAM~3 Peptide.  The TCR~'~y~ pos- 
sesses three TAM sequences, and on the average, only 2.7-2.9 
out of a possible 6 tyrosine residues are phosphorylated after 
an in vitro tyrosine phosphorylation with recombinant Lck. 
To better define the requirements for ZAP-70/TCtL~" inter- 
action, we performed binding studies with the tandem SH2 
Figure 1.  Specific  binding of tyrosine phosphoryhted TCR~'~ to GST- 
ZAP-70 fusion protein requires both the NH2- and the COOH-terminal 
SH2 domains. A synthetic peptide corresponding to the TCR~"  cytophsmic 
domain (TCIL~'~) was 32p phosphorylated  on tyrosine  residues using 
recombinant Lck and "y-[32p]ATP. The radiolabded  peptide, at the indi- 
cated amounts, was incubated with 3 #g of GST-ZAP-70 fusion proteins 
containing the tandem SH2 domains (,4),  the COOH-terminal (B) or 
NH2-terminal  (C)  SH2  domains,  or GST alone  (/9), immobilized  to 
glutathione agarose beads. After 1 h of incubation on a rotator at 4~ 
the beads were washed and and the bound radiolabeled  peptides were ehted 
and subjected to SDS-PAGE  under redudng conditions. An autoradiograph 
is shown. 
the GST fusion proteins immobilized to glutathione agarose 
beads. They were tested for their ability to bind a synthetic 
peptide consisting of the entire cytoplasmic portion of the 
TCK~" chain (TCK~'~yt). Recombinant Lck and 3,-[32p]ATP 
were used to phosphorylate the TCK~'r  peptide on tyro- 
sine residues in vitro (18). After incubation with various SH2 
constructs, the bound 32p-labeled  TCR~'cyt was released with 
SDS and was visualized by electrophoresis and autoradiog- 
raphy (Fig.  1).  The ZAP-70 tandem SH2  domains (GST- 
ZAP[SH2]2)  efficiently bound phosphorylated TCR~'~yt in- 
dicating  that  our  earlier  observations  represented  direct 
binding. Binding was saturable  and specific. The nonphos- 
phorylated  TCK~'cyt peptide  failed  to  compete  with  the 
phosphorylated peptide for binding. A GST fusion protein 
with  the  NH2-terminal  SH2  domain  (GST-ZAP[SH2]N) 
bound phosphorylated TCK~'~y, with an  ~100-fold lower 
affinity whereas no binding was observed with the C-SH2 
domain or with GST alone. 
qk- 
O 
e- 
.o 
a. 
120  A 
lOO 
8o 
6o 
4o 
2o 
0  --| 
￿9  001  .01  .1  1  1  0  100 
B  120- 
100 
80 
60 
40 
20 
0  ........  i 
.001  .01  .1  1  10  100 
Peptide Concentration (~tM) 
Figure 2.  Specific interaction between  GST-ZAP-70 and TAM~'3 re- 
quires the ZAP-70 tandem SH2 domains and phosphorylation  of the two 
tyrosine residues within the TAM. (.4) 2 #g GST-ZAP(SH2)2  (O), GST- 
ZAP(SH2)N (I), GST-ZAP(SH2)c (A), or GST (O),  immobilized to 
glutathione agarose beads, were incubated with the indicated concentra- 
tions of 3~-[32p]-labeled  (pTyr)2-TAM~'3  for 1 h on a rotator  at 4~  The 
beads were washed and bound radioactivity was measured. (B) 2 #g of 
immobilized GST-ZAP(SH2)2  were incubated with 4 nM of 32p-(pTyr)2- 
TAM~'3 in the presence or absence of cold (pTyr)z-TAM~'3  (O), (pTyr)tq- 
TAM~'3 (m), (pTyr)c-TAM~'3  (A), or TAM~'3  (O). Percentage of radiola- 
beled peptide bound was determined as in A. 
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synthesized, purified by HPLC, and tyrosine phosphorylated 
with  3'-[32P]ATP and  recombinant  Lck.  HPLC  was  per- 
formed on the peptide after phosphorylation. Fractions con- 
taining peptides were analyzed by mass spectrometry to iden- 
tify the doubly tyrosine phosphorylated peptide and the peak 
containing the mix of the two singly phosphorylated spe- 
cies. Direct binding studies using GST-ZAP(SH2)2  and the 
doubly phosphorylated peptide indicated that (pTyr)2-TAM~'3 
binding was  saturable.  GST-ZAP(SH2)2  bound  this phos- 
phopeptide at ,,~200-250-fold  higher affinity than the GST- 
ZAP(SH2)N (Fig. 2 A). No binding was observed with the 
GST-ZAP(SH2)c or the GST control protein. 
The  binding  of labeled  (pTYr)~-TAM~'3 to  ZAP(SH2)2 
could be competed with increasing concentrations of unla- 
beled (pTyr)2-TAM~'3. The concentration giving half-max- 
imal  inhibition  was  3-4  #M.  Peptides  with  only  one, 
(pTyr)c-TAM~'3 or  (pTYr)N-TAM~'3, or  neither of the  two 
tyrosines phosphorylated failed to compete (Fig. 2 B). A mix- 
ture of (pTyr)c-TAM~'3 and (pTyr)N-TAM~'3,  or of the two in- 
dividual hemi-TAMs,  LpYQGLST  and TpYDALHM,  each 
representing one half of a tyrosine phosphorylated TAM~'3, 
also failed  to compete with  32p-(pTyr)2-TAM~'3 binding to 
GST-ZAP(SH2)2  (not shown). 
Comparison of  TAM~'I, TAM~'2, TAM~'s, and  TAMe 
Binding Afinity.  Cytoplasmic domains of TCR  subunits 
contain six distinct TAM motifs, four of which, TAM,'l, 
TAM~'2, TAM~'z, and TAMe, are likely to be duplicated in 
each TCK.  Potentially, all of these TAM motifs may serve 
as docking sites for ZAP-70. However, the amino acid se- 
quence variability in TAMs, both between the paired tyro- 
sine residues, and between the tyrosine and isoleucine or leu- 
cine  residues,  provides  the  potential  for  specificity  of 
TAM-ligand interactions. To test whether we could detect 
differences  in TAM binding  specificity,  we compared the 
binding of four doubly phosphorylated TAM peptides to GST- 
ZAP(SH2)2.  Direct binding studies with 32p-labeled, doubly 
phosphorylated peptides demonstrated saturable binding of 
the four TAM peptides. 
The binding of labeled, doubly tyrosine phosphorylated 
TAM peptides to GST-ZAP(SH2)2  was used, this time for 
determination of the relative affinity of each TAM peptide 
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Figure 3.  The CD3e and each  of 
the three TCK~"  TAM motif-con- 
taining  peptides have different 
binding affinities  for the GST-ZAP 
(SH2)2 fusion protein. 2 #g of im- 
mobilized GST-ZAP(SH2)2 were 
incubated  with  3,-32p-labeled 
(pTyr)2-TAM  peptides (4 nM) de- 
rived  from  the first (A), second  (B), 
or third (C) TCK~', or the CD3e 
(D), TAM motifs, in the presence 
of  various concentrations  of  the in- 
dicated 'cold' peptides ([pTyr]2- 
TAM,'1 (O), [pTyr]2-TAM~'2  [rT], 
[pTyr]2-TAM~'3  [A], [pTyr]2-TAMe 
[O], [pTyr]c-TAM~'3  [A], [pTyr]N- 
TAM~'3 Jill]). After 1 h of incuba- 
tion on a rotator at 4~  the beads 
were washed and bound radioac- 
tivity was measured  by scintillation 
counting. 
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the four 32p-labeled TAM peptides was subjected to compe- 
tition analysis with these same four peptides.  Regardless of 
which peptide was labeled, the hierarchy of competition was 
the  same,  TAM~'I>--TAM~'2>TAMe~>TAM~'3. The relative 
apparent affinities of these peptides for GST-ZAP(SH2)2, as 
determined by competition (ICs0), varied between 0.1 and 
3 #M. A similar order of hierarchy was observed in a direct 
binding study using the four 32p-labeled TAM peptides (not 
shown). 
The TAM motif defines a module with potential for inter- 
actions mediated by different mechanisms. Residues between 
the tyrosines can determine binding of src-family tyrosine 
kinases as demonstrated in the B cell system (19). Likewise, 
the constitutive interaction of the Fyn PTK with the CD36 
TAM does not localize to the tyrosine residues (17). Tyrosine 
phosphorylation of a single tyrosine residue within a TAM 
potentially creates an additional binding site. The resulting 
sequence, pYXXI/L is recognized by SH2 domains of src- 
family kinases (20). Enhanced binding of these kinases after 
receptor phosphorylation may occur via this mechanism (21). 
Likewise, linker molecules such as SHC, which in turn bind 
Grb2 and Sos, may bind to tyrosine phosphorylated TAM 
sequences in this fashion (22). 
Published work from several laboratories  (15-17, 23) and 
these current data demonstate a third type of TAM-mediated 
interaction. Individually, the COOH-SH2 domain demon- 
strates  no binding and the NH2-SH2  domain binds only 
with low affinity to the phospho-TAMs. These new data dem- 
onstrate that the presence of the two SH2 domains, in tandem, 
raises the affinity for phosphoryhted  TAMs at least three orders 
of magnitude. Thus, this highly cooperative interaction of 
the tandem SH2 domains of ZAP-70 ensure a high level of 
specificity  of interaction with a doubly tyrosine phosphorylated 
TAM.  The activation of this  kinase,  which  accompanies 
binding, is thus tightly regulated at the level of assembly with 
receptor (24). Presumably,  similar rules apply for the inter- 
action of the Syk kinase with phosphorylated TAMs in B 
and mast cells. 
Our previous work (16) with the tandem SH2 domains 
of ZAP-70 demonstrated that GST-ZAP(SH2)2 could be used 
to precipitate tyrosine phosphorylated TCR subunits, as well 
as associated endogenous ZAP-70 kinase. These data indicate 
that the ZAP-70 SH2 domains can bind multiple TAMs. The 
current work confirms this result by demonstration of direct 
binding of GST-ZAP(SH2)2 to four of the six TCR TAMs. 
This observation provides further evidence for the sugges- 
tion that the presence of multiple TAMs offers the potential 
for binding multiple copies of a particular effector molecule, 
thus resulting in signal amplification (7). 
However, data have also been provided that support the 
possibility that individual TCR subunits and their TAMs are 
differentially coupled. In this regard, stimulation of T cells 
expressing receptor chimeras with either TCR~" or CD3e cy- 
toplasmic domains results in different patterns of substrate 
tyrosine phosphorylation (3). Two specific examples of TAM 
binding preference are the linker protein SHC, which binds 
phospho-TAM~3,  and not phospho-TAMe (22),  and phos- 
phatidylinositol (PI) 3-kinase, which associates with TAM,'1 
(25). The most striking results of this present study are the 
affinity differences of the four phospho-TAMs for the tandem 
ZAP SH2 domains. Regardless  of which of the four phos- 
phorylated TAMs was used for the binding studies, the hier- 
archy of binding demonstrated by competion was TAM~'I~ 
TAM~'2>TAMe~TAM~'3. The apparent affinities differed by 
as much as 30-fold. These observations provide further evi- 
dence of the capadty for TAM-binding specificity.  The marked 
sequence differences between TAMs outside of the conserved 
tyrosine and leucine/isoleucine residues have a significant effect 
on binding. The functional consequences of these affinity 
differences remain to be determined by careful mutagenesis 
studies. 
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Note added in proof: The term Tyrosine-based  Activation Motif (TAM) should be replaced with the term 
Immunoreceptor Tyrosine  based Activation Motif (ITAM). This nomenclature has recently been adopted 
by a group of investigators in the field. Aletter to this effect has been submitted for publication. 
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